Top

Published in:

04-05-2022 | Human Immunodeficiency Virus | Research Letter

Retrospective study of HIV drug resistance in Mexican children with vertically transmitted infection

Authors: Cristina de Jesús Herrera-Castillo, Angélica Maldonado-Rodríguez, Othón Rojas-Montes, Ana María Cevallos, José Guillermo Vázquez-Rosales, Rosalía Lira

Published in: World Journal of Pediatrics | Issue 7/2022

Excerpt

According to World Health Organization (WHO) estimates, in 2020, there were 1.8 million human immunodeficiency virus (HIV)-infected children below 15 years old living with HIV and 150,000 children who acquired the infection [1]. Every year, 110,000 children die as a consequence of acquired immune deficiency syndrome-related causes [2]. As in adults, optimal management of infected children depends on early diagnosis and treatment with antiretroviral drugs based on their viral genotype. …

UNAIDS. Global HIV statistics. Fact Sheet-World AIDS Day 2021. 2021. http://www.unaids.org/en/resources/fact-sheet. Accessed 6 Jan 2022.

EGPAF-WHO. Healthy topics. A new push for timely diagnosis and treatment of children with HIV. 2018. http://www.who.int/hiv/mediacentre/en/. Accessed 3 Jun 2019.

Mexican Secretary of Health DGE. Directorate general of epidemiology. Historical inform of HIV, first trimester of 2021. Epidemiological surveillance system of HIV. 2021. https://www.gob.mx/cms/uploads/attachment/file/622468/VIH-Sida_4toTrim_2020.pdf. Accessed 28 Aug 2021.

WHO. HIV/AIDS. Prevention of mother-to-child transmission estimates by country. 2017. http://apps.who.int/gho/data/view.main.23500?lang=en. Accessed 26 Dec 2018.

Soto-Ramirez LE, Rodriguez-Diaz R, Harris DR, Hazra R. HIV drug resistance-associated mutations in antiretroviral naive HIV-1-infected Latin American children. Adv Virol. 2010;2010:407476.CrossRef

Rojas Sánchez P, Holguín A. Drug resistance in the HIV-1-infected paediatric population worldwide: a systematic review. J Antimicrob Chemother. 2014;69:2032–42.CrossRef

AIDSinfo NIH. OARAC. Panel on antiretroviral therapy and medical management of children living with HIV. Guidelines for the use of antiretroviral agents in pediatric HIV infection. 2020. https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/PediatricGuidelines.pdf. Accessed 3 Sept 2021.

Afgan E, Baker D, van den Beek M, Blankenberg D, Bouvier D, Cech M, et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update. Nucleic Acids Res. 2016;44:W3-10.CrossRef

Inzaule S, Yang C, Kasembeli A, Nafisa L, Okonji J, Oyaro B, et al. Field evaluation of a broadly sensitive HIV-1 in-house genotyping assay for use with both plasma and dried blood spot specimens in a resource-limited country. J Clin Microbiol. 2013;51:529–39.CrossRef

10.

Avila-Rios S, Sued O, Rhee SY, Shafer RW, Reyes-Teran G, Ravasi G. Surveillance of HIV transmitted drug resistance in Latin America and the Caribbean: a systematic review and meta-analysis. PLoS One. 2016;11:e0158560.CrossRef

11.

Kipp W, Alibhai A, Saunders LD, Senthilselvan A, Kaler A, Konde-Lule J, et al. Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda. AIDS Care. 2010;22:271–8.CrossRef

12.

Castilho JL, Melekhin VV, Sterling TR. Sex differences in HIV outcomes in the highly active antiretroviral therapy era: a systematic review. AIDS Res Hum Retroviruses. 2014;30:446–56.CrossRef

13.

Karmochkine M, Si Mohamed A, Piketty C, Ginsburg C, Raguin G, Schneider-Fauveau V, et al. The cumulative occurrence of resistance mutations in the HIV-1 protease gene is associated with failure of salvage therapy with ritonavir and saquinavir in protease inhibitor-experienced patients. Antiviral Res. 2000;47:179–88.CrossRef

14.

Barber TJ, Harrison L, Asboe D, Williams I, Kirk S, Gilson R, et al. Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor. J Antimicrob Chemother. 2012;67:995–1000.CrossRef

15.

Mark D, Geng E, Vorkoper S, Essajee S, Bloch K, Willis N, et al. Making implementation science work for children and adolescents living with HIV. J Acquir Immune Defic Syndr. 2018;78(Suppl 1):S58-62.CrossRef

16.

Mexican Institute of Social Security. Guidelines on Prevention, Diagnostics and Treatment of mother to child transmission of HIV. 2016. http://www.imss.gob.mx/sites/all/statics/guiasclinicas/246GER.pdf. Accessed 28 Dec 2021.

Title: Retrospective study of HIV drug resistance in Mexican children with vertically transmitted infection
Authors: Cristina de Jesús Herrera-Castillo
Angélica Maldonado-Rodríguez
Othón Rojas-Montes
Ana María Cevallos
José Guillermo Vázquez-Rosales
Rosalía Lira
Publication date: 04-05-2022
Publisher: Springer Nature Singapore
Keyword: Human Immunodeficiency Virus
Published in: World Journal of Pediatrics / Issue 7/2022
Print ISSN: 1708-8569
Electronic ISSN: 1867-0687
DOI: https://doi.org/10.1007/s12519-022-00554-0

ACC 2024 Congress

Springer Medicine

Retrospective study of HIV drug resistance in Mexican children with vertically transmitted infection

Excerpt

ACC 2024 Congress

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 7/2022

Parental perception of child's weight, their attitudes towards child's dietary habits and the risk of obesity

Prevalence of congenital cytomegalovirus infection in preterm, small for gestational age and low birth weight newborns: characteristics and cytokines profile

Antenatal care positive responses to pregnant women in preventing and controlling malaria in pregnancy: the sub-Saharan African perspective

Congenital heart diseases trends in São Paulo State, Brazil: a national live birth data bank analysis

Fish oil-containing lipid emulsions prevention on parenteral nutrition-associated cholestasis in very low birth weight infants: a meta-analysis

X-linked osteogenesis imperfecta accompanied by patent ductus arteriosus: a case with a novel splice variant in PLS3